IPO’s Comments for the European Commission’s Review of the Design Directive and Community Design Regulation
IPO's Comments for the European Commission’s Review of the Design [...]
Letter to Incoming Biden Administration re: Importance of IP and Innovation
Letter to Incoming Biden Administration re: Importance of IP and [...]
IPO’s Comments to China’s Supreme People’s Court on Its Draft Provisions on Several Issues Concerning the Application of Law in the Trial of Patent Civil Cases Involving Drug Marketing Review and Approval
IPO's Comments to China’s Supreme People’s Court on Its Draft [...]
IPO’s Comments to the China National Intellectual Property Administration on Draft Amendments to the Patent Examination Guidelines
IPO's Comments to the China National Intellectual Property Administration on [...]
IPO’s Recommendations for USPTO Director Qualifications
IPO's Recommendations for USPTO Director Qualifications
Comments on Discretion to Institute Trials before the Patent Trial and Appeal Board
Comments on Discretion to Institute Trials before the Patent Trial [...]
IPO Comments to EPO Boards of Appeal on Amendment Addressing Hearings by VICO
IPO Comments to EPO Boards of Appeal on Amendment Addressing [...]
IPO Comments to India’s High Court of Delhi on Its Draft Rules Governing Patent Suits (2020)
IPO Comments to India’s High Court of Delhi on Its [...]
IPO Comments to U.S. Trade Representative re: the National Trade Estimate Report on Foreign Trade Barriers
IPO Comments to U.S. Trade Representative re: the National Trade [...]
IPO Comments on China’s draft Measures for the Implementation of Early Resolution Mechanisms for Drug Patent Disputes
IPO Comments on China’s draft Measures for the Implementation of [...]
Posts tagged here will show on the testimony and comments page.